EUVIMEDEUVIMED entdecken
Fallbericht

Overlapping drug‐induced vasculitis, ANCA‐associated vasculitis, and lupus nephritis caused by low‐dose hydralazine

M Bhatnagar, A Agaronov, E Sarkisyan, I Sotoudeh Deilamy, D Pepito, H Akhondi iD

International Journal of Rheumatic Diseases · 2023

DOI: 10.1111/1756-185x.14809 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Rheumatic Diseases, 2023. Verfasst von M Bhatnagar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sunrise Health GME Consortium, Mountain View Hospital, Las Vegas, Nevada, USA. Hauptthemen laut MEDLINE: Lupus Nephritis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Hypertension, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We present a case of drug‐induced vasculitis secondary to low‐dose hydralazine with overlapping features of antineutrophil cytoplasmic antibody‐associated vasculitis and drug‐induced lupus nephritis. Case presentation A 52‐year‐old Hispanic woman with a medical history of resistant hypertension treated with hydralazine 10 mg twice daily for 1 year presented with generalized weakness, dizziness, nausea, vomiting, and gross hematuria. There was fever, tachycardia, leukocytosis, lactic acidosis, hyperkalemia, renal failure, and anemia. Chest computed tomography and bronchoscopy revealed a left lower lobe infiltrate and diffuse alveolar hemorrhage. Serologic testing was positive for anti‐double‐stranded DNA, anti‐Smith, lupus anticoagulant, anti‐histone, anti‐cardiolipin IgM antibodies, and antineutrophil cytoplasmic antibodies (myeloperoxidase and proteinase 3). A kidney biopsy revealed crescentic glomerulonephritis with an overlapping finding of membranous nephropathy. Broad‐spectrum antibiotics, immunosuppressants, corticosteroids, and plasmapheresis were initiated. The patient survived but required continuous hemodialysis.

Conclusions

Although a few cases of simultaneous antibody‐associated vasculitis and drug‐induced lupus nephritis secondary to hydralazine use have been reported, this case is singular. Similar findings were previously reported with doses of 50–100 mg two to three times daily over 1–5 years. In our patient, a dose of only 10 mg twice daily for a year caused a severe disease presentation. This brings to light the combination of different vasculitides that can coexist and the potentially life‐threatening adverse effects of low‐dose hydralazine that should be kept in mind.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisHypertensionLupus Erythematosus, SystemicRenal InsufficiencyFemaleHumansMiddle AgedHydralazineAntibodies, Antineutrophil Cytoplasmic

Stichwörter der Autor:innen

antineutrophil cytoplasmic antibody-associated vasculitisdrug-induced vasculitishydralazinelupus nephritisvasculitis

Substanzen

HydralazineAntibodies, Antineutrophil Cytoplasmic

Autor:innen und Institutionen

  • Sunrise Health GME Consortium, Mountain View Hospital, Las Vegas, Nevada, USA.
  • College of Osteopathic Medicine, Touro University Nevada, Henderson, Nevada, USA.
  • Valley Health System, Las Vegas, Nevada, USA.

ORCID-Profile: H Akhondi

Zitieren

APA

Bhatnagar, M., Agaronov, A., Sarkisyan, E., Sotoudeh Deilamy, I., Pepito, D., & Akhondi, H. (2023). Overlapping drug‐induced vasculitis, ANCA‐associated vasculitis, and lupus nephritis caused by low‐dose hydralazine. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.14809

Vancouver

Bhatnagar M, Agaronov A, Sarkisyan E, Sotoudeh Deilamy I, Pepito D, Akhondi H. Overlapping drug‐induced vasculitis, ANCA‐associated vasculitis, and lupus nephritis caused by low‐dose hydralazine. International Journal of Rheumatic Diseases. 2023. doi:10.1111/1756-185x.14809

BibTeX
@article{Bhatnagar2023,
  author = {Bhatnagar, M and Agaronov, A and Sarkisyan, E and Sotoudeh Deilamy, I and Pepito, D and Akhondi, H},
  title = {Overlapping drug‐induced vasculitis, ANCA‐associated vasculitis, and lupus nephritis caused by low‐dose hydralazine},
  journal = {International Journal of Rheumatic Diseases},
  year = {2023},
  doi = {10.1111/1756-185x.14809}
}
Kostenlos starten →